
The Luminelle DTx Hysteroscopy System can be used in-office by physicians to visually assess suspicious tissue in the uterus and allow for a visually-aided biopsy.

The Luminelle DTx Hysteroscopy System can be used in-office by physicians to visually assess suspicious tissue in the uterus and allow for a visually-aided biopsy.

Compared to those with LDL cholesterol levels 160 mg/dL had a 70-90% increased risk.

The results of a new study indicate that most physicians are not following the CDC’s recommendation to screen all Baby Boomers for hepatitis C.

How issues with pain in patients with Lyme disease or opioid-induced constipation can be managed in a timely, efficient manner.

The Childhood Behavior Checklist may help primary care physicians determine if young children are at risk for developing major depressive disorder or anxiety disorders in their teenage and young adult years.

A modified 12-week dosing schedule is now available for physicians administering the vascular endothelial growth factor (VEGF) inhibitor to patients with wet age-related macular degeneration.

Experts argue that oral corticosteroids should be available at home for early use in asthma exacerbation.

The celebrity chef-turned-producer wants to champion healthcare access, both on the screen and in person. Where does he start?

The guidelines from the American Academy of Neurology highlight the need to improve diagnosis and ongoing rehabilitative care for patients with disorders of consciousness.

A Denmark retrospective study of 7 million-plus individuals found associations between increased TBI severity and frequency, and suicide risk.

Chervenak was recently appointed chair of the department of obstetrics and gynecology at Lenox Hill Hospital and chair of the academic department of obstetrics & gynecology and associate dean for international medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Participants in the Project LifeSkills intervention had a 39.8% greater mean reduction in condomless sex compared to participants receiving standard care.

If approved in early 2019, the nasal spray would become the first approved therapy indicated for seizure clusters in 17 years.

Over time, it has become evident that suicide involves a complex mix of genetics, temperament, circumstances, external support, and access to means.

The Annovera combines segesterone acetate and ethinyl estradiol to prevent pregnancy and has a 2-4% failure rate.

Patisiran also makes history as the first FDA-approved small interfering ribonucleic acid treatment, a class of drugs that silences the portion of RNA involved in causing the disease.

Natural Cycles requires women enter a daily basal thermometer body temperature to detect minor rises in temperature at the time of ovulation. It also tracks the user’s menstrual cycle.

In a systematic review and meta-analysis, low-quality drugs are most prevalent low- to middle-income countries, and can cost up to $200 billion annually.

According to pooled data, 91.8% of the hospitalizations due to firearm injuries in pediatric and adolescent patients were of urban patients, 4.8% were of micropolitan patients, and 3.3% were of rural patients.

Through Warrior Centric Health, the 25-year US Navy vet has bridged the gap between civilian physicians and the specific-need veterans left behind.

In a trio of phase 3 studies, omadacycline met the FDA-designated primary and secondary efficacy outcomes while reporting consistent safety measures and tolerability.

The potassium chloride oral solution was approved through the new approval pathway for drugs with no other approved competitors.

For patients with acute coronary syndrome and depression, taking escitalopram to treat depression resulted in significantly fewer major cardiac events compared to patients given placebo.

The REGENXBIO drug's promising phase 1 results has led to the addition of a fourth patient dosing cohort and a phase 2 trial initiation.

A retrospective study showed a probability of maintaining HIV viral suppression of 98.2% at 48 weeks and 95.1% at 96 weeks, with the switch to the dolutegravir/lamivudine antiretroviral regimen.